A new study, May P.A. et al. (2020), was conducted by researchers associated with the Emory University School of Medicine’s Collaboration on FASD Prevalence (CoFASP) consortium. CoFASP is a medical research organization whose aim is to determine how prevalent FASD is in the United States by providing diagnostic services to four communities in California, North Carolina, and the Midwest. They do this by offering evaluation and diagnostic services to school-age children in the communities selected and logging how many children fit the criteria for FASD.

Out of the four CoFASP communities, the one referred to in this study has the lowest prevalence of FASD. Even with a comparatively low prevalence, FASD seems to be common. Nationally, prior research has indicated that FASD may affect anywhere between 1.1-5% of the population, which is 3 million to 16 million Americans, or 64,000 to 291,000 Wisconsinites.

©2021 Orchids FASD Services of Wisconsin, Inc. All Rights Reserved.
Orchids is a 501(c)(3) non-profit organization.

Orchids is the NOFAS Affiliate in Wisconsin.

This site is provided to families and professionals as an informative site on fetal alcohol spectrum disorders (FASD). It is not intended to replace professional medical, psychological, behavioral, legal, nutritional or educational counsel. Reference to any specific agency does not necessarily constitute or imply its endorsement, recommendation, or favoring by Orchids FASD Services.
Privacy Policy